Retapamulin Microdialysis Feasibility Study

Clinical trial NCT01812382 · COMPLETED

Trial details

NCT number: NCT01812382
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Skin Infections, Bacterial

Start date: 2014-04-02
Primary completion: 2014-05-27
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.